Modus Therapeutics
Invitation to investor meeting with Modus Therapeutics Holding AB
On March 9, John Öhd, CEO of Modus Therapeutics Holding AB, will participate in the Small Cap Invest investor meeting.
Modus Therapeutics is aiming for a paradigm shift in treatment for sepsis, one of the deadliest and most expensive medical conditions in the world. John Öhd provides a status update based on the recently published positive top-line data from the company's Phase 1b LPS challenge study evaluating the potential of sevuparin as a new treatment for sepsis. After the presentation of approximately 20 minutes, there is an opportunity to ask questions.
Date: Thursday March 9 at 14:00
Notification: https://small-cap-invest.confetti.events/
About Small Cap Invest
Dagens PS investor meeting, Small Cap Invest, is a free and digital investor meeting.
Interesting cases are presented here that provide you with a safe basis for investing in the presenting companies. During the investor meeting, you are also given the opportunity to ask questions to the companies.
Datum | 2023-03-07, kl 09:00 |
Källa | MFN |
